Betacellulin regulates hair follicle development and hair cycle induction and enhances angiogenesis in wounded skin.
暂无分享,去创建一个
P. Bugnon | E. Wolf | S. Werner | R. Paus | S. Hasse | M. Dahlhoff | M. Antsiferova | L. Feldmeyer | M. Schneider
[1] A. Pollins,et al. Modulation of porcine wound repair with a transfected ErbB3 gene and relevant EGF-like ligands. , 2007, The Journal of investigative dermatology.
[2] K. Jang,et al. Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis. , 2006, Human pathology.
[3] E. Birgitte Lane,et al. New consensus nomenclature for mammalian keratins , 2006, The Journal of cell biology.
[4] A. Citri,et al. EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.
[5] J. Voorhees,et al. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. , 2006, The Journal of investigative dermatology.
[6] R. Wanke,et al. Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. , 2005, Endocrinology.
[7] S. Werner,et al. Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. , 2005, The American journal of pathology.
[8] E. Mekada,et al. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing , 2005, Journal of Cell Science.
[9] A. Citri,et al. Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity* , 2005, Journal of Biological Chemistry.
[10] S. Cross,et al. Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor , 2004, Mammalian Genome.
[11] M. Pittelkow,et al. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early‐onset, psoriasis‐like skin pathology: Expression of amphiregulin in the basal epidermis is also associated with synovitis , 2004, Experimental dermatology.
[12] Geoffrey C Gurtner,et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. , 2004, The American journal of pathology.
[13] G. Weskamp,et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.
[14] N. Hynes,et al. ErbB receptors: directing key signaling networks throughout life. , 2004, Annual review of pharmacology and toxicology.
[15] S. Chan,et al. Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle* , 2003, Journal of Biological Chemistry.
[16] S. Werner,et al. Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.
[17] R. Underwood,et al. Proliferation–differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes , 2003, Archives of Dermatological Research.
[18] Robert J Coffey,et al. EGF receptor ligands. , 2003, Experimental cell research.
[19] S. Werner,et al. Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] C. Cho,et al. Betacellulin induces angiogenesis through activation of mitogen‐activated protein kinase and phosphatidylinositol 3’‐kinase in endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] C. Dinney,et al. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] Elaine Fuchs,et al. Getting under the skin of epidermal morphogenesis , 2002, Nature Reviews Genetics.
[23] P. A. Harding,et al. Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. , 2002, The Journal of burn care & rehabilitation.
[24] M. Pittelkow,et al. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation. , 2001, Experimental cell research.
[25] Injoong Kim,et al. Wound epithelialization deficits in the transforming growth factor‐α knockout mouse , 2001 .
[26] R Paus,et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. , 2001, The Journal of investigative dermatology.
[27] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[28] R. Timpl,et al. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Y. Matsuzawa,et al. Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound Healing , 2000, The Journal of cell biology.
[30] A. J. Dunbar,et al. Structure-function and biological role of betacellulin. , 2000, The international journal of biochemistry & cell biology.
[31] Fiona M. Watt,et al. The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development , 2000, Cell.
[32] S. Yuspa,et al. The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. , 2000, Cancer research.
[33] D B Evans,et al. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] D. Roop,et al. Transgenic coexpression of v‐Ha‐ras and transforming growth factor α increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c‐Ha‐ras activation , 2000, Molecular carcinogenesis.
[35] K. Sayama,et al. Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes* , 2000, The Journal of Biological Chemistry.
[36] D. Roop,et al. 12‐O‐tetradecanoylphorbol‐13‐acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor‐α and v‐fos: acceleration of autonomous papilloma formation and malignant conversion via c‐Ha‐ras activation , 1999, Molecular carcinogenesis.
[37] A. Alonso,et al. EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT. , 1999, Experimental cell research.
[38] R Paus,et al. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. , 1999, The Journal of investigative dermatology.
[39] L. Hudson,et al. Contributions of the epidermal growth factor receptor to keratinocyte motility , 1998, Microscopy research and technique.
[40] James T. Elder,et al. Retinoid regulation of heparin‐binding EGF‐like growth factor gene expression in human keratinocytes and skin * , 1998, Experimental dermatology.
[41] M. Pittelkow,et al. Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. , 1998, The Journal of investigative dermatology.
[42] K. Kiguchi,et al. Altered expression of epidermal growth factor receptor ligands in tumor promoter–treated mouse epidermis and in primary mouse skin tumors induced by an initiation‐promotion protocol , 1998, Molecular carcinogenesis.
[43] M. Pittelkow,et al. EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. , 1997, The Journal of investigative dermatology.
[44] J. Brown,et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. , 1997, The Journal of clinical investigation.
[45] D. Riethmacher,et al. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor , 1997, Nature.
[46] James T. Elder,et al. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture. , 1997, The Journal of clinical investigation.
[47] T. Magnuson,et al. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. , 1997, The American journal of pathology.
[48] J. Ward,et al. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor‐α‐induced epidermal growth factor receptor activation but not p53 inactivation , 1997, Molecular carcinogenesis.
[49] M. Piepkorn,et al. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. , 1996, The American Journal of dermatopathology.
[50] Kuo-Fen Lee,et al. Requirement for neuregulin receptor erbB2 in neural and cardiac development , 1995, Nature.
[51] Rüdiger Klein,et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.
[52] A. Ullrich,et al. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. , 1995, The EMBO journal.
[53] M. Klagsbrun,et al. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. , 1995, Molecular biology of the cell.
[54] R. Derynck,et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor , 1995, Nature.
[55] E. Wagner,et al. Strain-dependent epithelial defects in mice lacking the EGF receptor. , 1995, Science.
[56] K. Herrup,et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.
[57] M. Klagsbrun,et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor , 1995, The Journal of cell biology.
[58] P. Hofschneider,et al. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. , 1994, Science.
[59] S. Werner,et al. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. , 1994, The Journal of investigative dermatology.
[60] H. Asada,et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. , 1994, The Journal of biological chemistry.
[61] D. Roop,et al. Epidermal expression of transforming growth factor‐α in transgenic mice: Induction of spontaneous and 12‐O‐tetradecanoylphorbol‐13‐acetate‐induced papillomas via a mechanism independent of Ha‐ras activation or overexpression , 1994, Molecular carcinogenesis.
[62] G. Merlino,et al. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[63] G. Plowman,et al. Amphiregulin‐dependent proliferation of cultured human keratinocytes: Autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin‐like glycosaminoglycans , 1994, Journal of cellular physiology.
[64] N. Copeland,et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. , 1994, Genes & development.
[65] D. Roop,et al. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[66] S. Werner,et al. Targeted expression of a dominant‐negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. , 1993, The EMBO journal.
[67] M. Klagsbrun,et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[68] E. Nice,et al. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation , 1993, Cell.
[69] David C. Lee,et al. TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice , 1993, Cell.
[70] E. Fuchs,et al. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. , 1993, The EMBO journal.
[71] E. Fuchs,et al. Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis , 1992, Molecular and cellular biology.
[72] N. Lemoine,et al. Expression of the c-erbB-3 protein in normal human adult and fetal tissues. , 1992, Oncogene.
[73] L. Nanney,et al. Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. , 1992, The Journal of investigative dermatology.
[74] E. Fuchs,et al. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. , 1991, Genes & development.
[75] J. Adelman,et al. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin , 1991, Molecular and cellular biology.
[76] L. Nanney,et al. Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. , 1990, The Journal of investigative dermatology.
[77] C. Cordon-Cardo,et al. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.
[78] D. Greenhalgh,et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.
[79] Gary R. Grotendorst,et al. EGF and TGF‐alpha are potent chemoattractants for endothelial cells and EGF‐like peptides are present at sites of tissue regeneration , 1989, Journal of cellular physiology.
[80] R. Derynck,et al. Transmembrane TGF-α precursors activate EGF/TGF-α receptors , 1989, Cell.
[81] James T. Elder,et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. , 1989, Science.
[82] J. Massagué,et al. The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction , 1989, Cell.
[83] D. Goeddel,et al. Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .
[84] H. Modjtahedi,et al. Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells , 2004, Clinical & Experimental Metastasis.
[85] R Paus,et al. Controls of hair follicle cycling. , 2001, Physiological reviews.
[86] James T. Elder,et al. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. , 2001, Neoplasia.
[87] G. Besner,et al. Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. , 1996, The Journal of investigative dermatology.
[88] Harold L. Moses,et al. Production and auto-induction of transforming growth factor-α in human keratinocytes , 1987, Nature.
[89] N. Nomura,et al. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. , 1986, Cancer research.